Figure 2.
Schmetic of low expression of ESCO2 mRNA that is correlated with poor outcome in CRC.
Notes: (A) The prognostic implication of ESCO2 was revealed by Kaplan–Meier analysis in the HMH cohort. Low expression of ESCO2 mRNA was correlated with unfavorable overall survival (left panel) and disease-free (right panel) survival. (B) The prognostic value of ESCO2 was confirmed in the TCGA cohort.
Abbreviations: CRC, colorectal cancer; TCGA, The Cancer Genome Atlas.